503b bulks exclusion
Semaglutide vs 503B Bulks - How to Choose
Excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list could cost hospitals as much as $200 million per year in added drug costs. That figure reflects the combined price differential between bulk-compounded GLP-1 products and commercially sourced injectables, a gap that will widen as compounding pharmacies lose access to